Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Astrazeneca LP. v. Mylan Pharmaceuticals Inc., No. 11-1506 (Fed. Cir. Apr. 9, 2012)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 11-1506
Decided
April 9, 2012
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
2 pages

NOTE: This disposition is nonprecedential.

United States Court of Appeals

for the Federal Circuit ASTRAZENECA LP, AKTIEBOLAGET DRACO,

KBI INC., AND KBI-E INC.,

Plaintiffs-Appellants,

v.

MYLAN PHARMACEUTICALS INC.,

Defendant-Appellee.

2011-1506

Appeal from the United States District Court for the District of Delaware in No. 08-CV-0453, Chief Judge Gregory M. Sleet.

JUDGMENT

GEORGE F. PAPPAS, Covington & Burling LLP, of Washington, DC, argued for plaintiffs-appellants. With him on the brief were JEFFREY B. ELIKAN and MICHELLE L. MORIN.

NICOLE W. STAFFORD, Wilson Sonsini Goodrich & Rosati, of Austin, Texas, argued for defendant-appellee. With her on the brief were ROBERT DELAFIELD; DAVID S.

2STEUER and MATTHEW A. ARGENTI, of Palo Alto, California. THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT April 9, 2012 /s/ Jan Horbaly Date Jan Horbaly Clerk

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Astrazeneca LP. v. Mylan Pharmaceuticals Inc., No. 11-1506 (Fed. Cir. Apr. 9, 2012).

Record ID
CAFC-11-1506-20120409
Permalink
https://patentcasewatch.com/opinions/CAFC-11-1506-20120409

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.